Kerofin
The computed 12-month bankruptcy probability of Kerofin is 0.4% (very low). The 2024 annual accounts show equity of €150k and a net result of €77k. Equity is growing by ~101.1% per year across the filed fiscal years. Its solvency ranks better than 63% of 12428 sector peers (fiscal year 2024). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €150k |
| Net result | €77k |
| Better than sector | 63% |
| Active | 3 yrs |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 70.0% | 60.6% | |
| Net result | €77k | €31k | |
| Equity | €150k | €63k | |
| Gross operating margin | €107k | €52k | |
| Total assets | €215k | €124k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €105k |
| Net profit | €77k |
| Cash flow | €78k |
| Staff costs | - |
| Income taxes | €22k |
| Dividends | - |
| Total assets | €215k |
| Equity | €150k |
| Debt | €64k |
| of which ≤ 1y | €64k |
| of which > 1y | - |
| Working capital | €147k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 3.29 |
| Quick ratio | 3.29 |
| Working capital ratio | 68.5% |
| Solvency | 70.0% |
| Debt / equity | 0.43 |
| Long-term debt ratio | - |
| Interest coverage | 19.74 |
| Gross margin | - |
| Net margin | - |
| ROA | 35.9% |
| ROE | 51.3% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €215k |
| Fixed assets | 21/28 | €3k |
| Tangible fixed assets | 22/27 | €3k |
| Current assets | 29/58 | €212k |
| Amounts receivable within one year | 40/41 | €82k |
| Cash & bank | 54/58 | €121k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €215k |
| Equity | 10/15 | €150k |
| Contributions / capital | 10/11 | €2k |
| Reserves | 13 | €148k |
| Amounts payable | 17/49 | €64k |
| Amounts payable within one year | 42/48 | €64k |
| Trade debts payable within one year | 44 | €3k |
| Income statement | ||
| Gross operating margin | 9900 | €107k |
| Operating result | 9901 | €104k |
| Financial income | 75 | €141 |
| Financial charges | 65 | €5k |
| Result before taxes | 9903 | €99k |
| Income taxes | 67/77 | €22k |
| Net result for the period | 9904 | €77k |
| Result to be appropriated | 9905 | €77k |
| NACE primary | Head office activities(70100) |
| Legal form | Private limited company(610) |
| Incorporation | 18-08-2022 |
| Status | Active |
| Postal code | 9880 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44001B0013/00P002 | Flanders | 1,724 m² | 1 · 369 m² | 9.0 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
21-02-2024 Registered office moved from Heusden-Zolder to Aalter
- Pater Amideuslaan 12, 3550 Heusden-Zolder → Ambachtenlaan 2, 9880 Aalter
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "Ambachtenlaan 2, 9880 Aalter",
"city": "Aalter",
"region": "vlaams_gewest",
"street": "Ambachtenlaan",
"country": "BE",
"postcode": "9880",
"box_number": null,
"street_number": "2",
"locality_suffix": null
},
"old_address": {
"raw": "Pater Amideuslaan 12, 3550 Heusden-Zolder",
"city": "Heusden-Zolder",
"region": "vlaams_gewest",
"street": "Pater Amideuslaan",
"country": "BE",
"postcode": "3550",
"box_number": null,
"street_number": "12",
"locality_suffix": null
},
"effective_date": "2023-11-10",
"evidence_quote": "",
"region_changed": false,
"is_statute_change": true,
"nationality_change": false,
"old_address_source": "header_volledig_adres",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "immediate",
"statutaire_vs_werkelijke": null,
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-02-21",
"filing_date": "2024-02-12",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "bijzondere_algemene_vergadering",
"date": "2023-11-10",
"unanimous": null
},
"subject_company": {
"kbo": "0789.728.567",
"name_full": "Kerofin",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "org",
"org_kbo": "0440.567.565",
"org_name": "I.B.A. Integraal bedrijfsadvies",
"person_name": null,
"org_rep_person_name": "Koen Kortleven",
"person_role_at_subject": null
},
"co_filed_documents": [
"publicatieformulieren 1 en 2"
]
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | Kerofin |